Testimony on Developing Cancer Biomarkers

A Case Study Involving ACF/Orlistat (Xenical)


June 15, 2006

Sidney M. Wolfe M.D.
Public Citizen’s Health Research Group
Biomarkers for Screening, Diagnosis and Treatment of Cancer:
Why Not for Harm Prevention as Well?
A Case Study Involving ACF/Orlistat 

Institute of Medicine, Committee on Developing Cancer Biomarkers

Presentation slides (pdf)